These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 3719555)
21. Primary treatment of stage III ovarian carcinoma with sequential chemotherapy and whole abdominal radiation therapy. Reid GC; Roberts JA; Hopkins MP; Schoeppel SL; Perez-Tamayo C; Drescher C; Chamberlain D; Morley GW Gynecol Oncol; 1993 Jun; 49(3):333-8. PubMed ID: 8314535 [TBL] [Abstract][Full Text] [Related]
22. Stage III ovarian carcinoma: an analysis of treatment results and complications following hyperfractionated abdominopelvic irradiation for salvage. Fein DA; Morgan LS; Marcus RB; Mendenhall WM; Sombeck MD; Freeman DE; Million RR Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):169-76. PubMed ID: 8175425 [TBL] [Abstract][Full Text] [Related]
24. Complications of whole abdominal and pelvic radiotherapy following chemotherapy for advanced ovarian cancer. Whelan TJ; Dembo AJ; Bush RS; Sturgeon JF; Fine S; Pringle JF; Rawlings GA; Thomas GM; Simm J Int J Radiat Oncol Biol Phys; 1992; 22(5):853-8. PubMed ID: 1555976 [TBL] [Abstract][Full Text] [Related]
25. Abdomino pelvic irradiation after second-look laparotomy for stage III ovarian carcinoma. Chapet S; Berger C; Fignon A; Calais G; Fetissof F; Reynaud-Bougnoux A; Descamps P; Body G; Lansac J; le Floch O Eur J Obstet Gynecol Reprod Biol; 1995 Sep; 62(1):43-8. PubMed ID: 7493707 [TBL] [Abstract][Full Text] [Related]
26. Sequential multi-agent chemotherapy and whole abdominal irradiation for stage III ovarian carcinoma. Rosen EM; Goldberg ID; Rose C; Come S; Goldstein M; Simon L; Botnick LE Radiother Oncol; 1986 Nov; 7(3):223-31. PubMed ID: 3809585 [TBL] [Abstract][Full Text] [Related]
27. Selective irradiation for the treatment of recurrent ovarian carcinoma involving the vagina or rectum. Firat S; Erickson B Gynecol Oncol; 2001 Feb; 80(2):213-20. PubMed ID: 11161862 [TBL] [Abstract][Full Text] [Related]
28. Whole abdomen radiation therapy after a short chemotherapy course and second-look laparotomy in advanced ovarian cancer. Franchin G; Tumolo S; Scarabelli C; De Paoli A; Boz G; Crivellari D; Arcicasa M; Bortolus R; Gobitti C; Minatel E Gynecol Oncol; 1991 Jun; 41(3):206-11. PubMed ID: 1869096 [TBL] [Abstract][Full Text] [Related]
29. Abdominopelvic irradiation for persistent advanced ovarian carcinoma. Stephenson JA; Buchler DA Int J Radiat Oncol Biol Phys; 1989 Aug; 17(2):385-8. PubMed ID: 2753763 [TBL] [Abstract][Full Text] [Related]
30. [Total abdominal irradiation following combination chemotherapy and second-look laparotomy in the treatment of advanced ovarian cancer]. Greiner R; Goldhirsch A; Dreher E; Locher G; Jeanneret C; Meister A; Mihic N; Veraguth P Onkologie; 1985 Dec; 8(6):364-72. PubMed ID: 3005937 [TBL] [Abstract][Full Text] [Related]
31. Intraperitoneal chromic phosphate P 32 as salvage therapy for persistent carcinoma of the ovary after surgical restaging. Soper JT; Wilkinson RH; Bandy LC; Clarke-Pearson DL; Creasman WT Am J Obstet Gynecol; 1987 May; 156(5):1153-8. PubMed ID: 3578429 [TBL] [Abstract][Full Text] [Related]
32. Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma. Louie KG; Ozols RF; Myers CE; Ostchega Y; Jenkins J; Howser D; Young RC J Clin Oncol; 1986 Nov; 4(11):1579-85. PubMed ID: 3095501 [TBL] [Abstract][Full Text] [Related]
34. Whole-abdomen radiation therapy in ovarian carcinoma: its role as a salvage therapeutic modality. Reddy S; Hartsell W; Graham J; Yordan EL; Lee MS; Sarin P; Phillips AK; McIntosh D; Wilbanks G Gynecol Oncol; 1989 Dec; 35(3):307-13. PubMed ID: 2599465 [TBL] [Abstract][Full Text] [Related]
35. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response. Vaccarello L; Rubin SC; Vlamis V; Wong G; Jones WB; Lewis JL; Hoskins WJ Gynecol Oncol; 1995 Apr; 57(1):61-5. PubMed ID: 7705701 [TBL] [Abstract][Full Text] [Related]
36. Critical reassessment of second-look exploratory laparotomy for epithelial ovarian carcinoma. Minimal diagnostic and therapeutic value in patients with persistent cancer. Miller DS; Spirtos NM; Ballon SC; Cox RS; Soriero OM; Teng NN Cancer; 1992 Jan; 69(2):502-10. PubMed ID: 1728381 [TBL] [Abstract][Full Text] [Related]
37. A randomized trial comparing single-agent carboplatin with carboplatin followed by radiotherapy for advanced ovarian cancer: a North Thames Ovary Group study. Lambert HE; Rustin GJ; Gregory WM; Nelstrop AE J Clin Oncol; 1993 Mar; 11(3):440-8. PubMed ID: 8445418 [TBL] [Abstract][Full Text] [Related]
38. Recurrent disease after negative second-look laparotomy in stages III and IV ovarian carcinoma. Podratz KC; Malkasian GD; Wieand HS; Cha SS; Lee RA; Stanhope CR; Williams TJ Gynecol Oncol; 1988 Mar; 29(3):274-82. PubMed ID: 3345949 [TBL] [Abstract][Full Text] [Related]